---
title: "HYBIO: Signed a series of commercialization agreements with Sanofi, with the weight loss drug expected to reach a peak annual sales of 30 million units"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253704587.md"
description: "HYBIO has signed a series of commercialization agreements with Zhejiang Sanofi-Mandi Pharmaceutical, including the \"Semaglutide Injection Entrusted Production and Supply Agreement\" and the \"Quality Agreement.\" According to the agreements, the expected annual sales peak is 30 million units, and the supply price will be quoted in phases based on sales forecasts. The drug will be co-produced as a Class 2 modified new drug in China and the United States"
datetime: "2025-08-19T23:26:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253704587.md)
  - [en](https://longbridge.com/en/news/253704587.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253704587.md)
---

# HYBIO: Signed a series of commercialization agreements with Sanofi, with the weight loss drug expected to reach a peak annual sales of 30 million units

On August 19th, HYBIO officially signed a series of commercialization documents including the "Contract Manufacturing and Supply Agreement for Semaglutide Injection" and the "Quality Agreement" with Zhejiang SanSheng ManDi Pharmaceutical Co., Ltd. in Beijing. According to the agreement, the supply price will be based on non-binding sales forecasts, with phased cost calculations and tiered pricing according to annual purchase volumes of ≤5 million, 5–10 million, and \>10 million units, with an expected annual sales peak of 30 million units. The Semaglutide Injection for this cooperation will be filed as a Class 2 modified new drug and will be produced concurrently in China and the United States

### Related Stocks

- [300199.CN](https://longbridge.com/en/quote/300199.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [PRECIOUS-Gold steadies as high Treasury yields offset Mideast peace hopes](https://longbridge.com/en/news/287040685.md)
- [Wheat Falling Lower on Wednesday](https://longbridge.com/en/news/287109880.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)
- [TECHNICALS-CBOT wheat may test resistance zone of $6.80-3/4 to $6.82-1/2](https://longbridge.com/en/news/286875766.md)